5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum.

Let's take a closer look at five of this past week's biggest scorchers.

Company

March 30 Weekly Gain My Watchlist
Amylin Pharmaceuticals (Nasdaq: AMLN  ) $24.96 61% Add
Xinyuan Real Estate (NYSE: XIN  ) $3.47 31% Add
Arena Pharmaceuticals (Nasdaq: ARNA  ) $3.08 28% Add
Brightcove (Nasdaq: BCOV  ) $24.80 18% Add
Caesars Entertainment (Nasdaq: CZR  ) $14.74 18% Add

Source: Barron's.

Amylin was one of last week's biggest winners, soaring more than 60% after reportedly rejecting an unsolicited buyout offer for $3.5 billion.

Xinyuan Real Estate hit a fresh 52-week high on Friday, now more than doubling from its October lows. There was no material news on the Chinese homebuilder -- outside of receiving a pair of awards from a China study group -- but growth stocks in the world's most populous nation have been bouncing back after a rough 2011.

Arena Pharmaceuticals soared after a Food and Drug Administration advisory panel voted in favor of more stringent clinical testing on obesity drugs. Yes, Arena already has a treatment -- lorcaserin -- currently under review, but this move will make it harder for rival treatments in the future to hit the market sooner.

Five different analysts initiated coverage of Brightcove with bullish ratings last week. Sure, these also happen to be the same five firms that served as lead underwriters during the company's February IPO, but praise -- in concert -- is praise nonetheless.

Caesars Entertainment hit the jackpot after Moody's Investors Service upgraded the casino operator's credit rating. An improving economy is a good catalyst for growth in the gaming niche.

More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.


Read/Post Comments (1) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 02, 2012, at 11:59 AM, montys3 wrote:

    Little info. about XIN. Once they announce more buybacks & the switch to quarterly dividends from yearly it will get to book value quick!!!

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1852869, ~/Articles/ArticleHandler.aspx, 12/19/2014 7:20:49 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement